SPONSOR
SCRI Development Innovations, LLC
Total Trials
2
Recruiting
2
Phases
Phase 2
Conditions studied: Colon CancerRectal CancerColorectal CancerColorectal Cancer (CRC)Multiple Myeloma, Newly DiagnosedMultiple Myeloma (MM)
SCRI Development Innovations, LLC is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Colon Cancer, Rectal Cancer, Colorectal Cancer, Colorectal Cancer (CRC).
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — SCRI Development Innovations, LLC
How many clinical trials has SCRI Development Innovations, LLC sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by SCRI Development Innovations, LLC, of which 2 are actively recruiting participants. These trials cover conditions including Colon Cancer, Rectal Cancer, Colorectal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does SCRI Development Innovations, LLC research focus on?
SCRI Development Innovations, LLC clinical trials span Colon Cancer, Rectal Cancer, Colorectal Cancer, Colorectal Cancer (CRC), Multiple Myeloma, Newly Diagnosed, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a SCRI Development Innovations, LLC clinical trial?
To participate in a SCRI Development Innovations, LLC trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all SCRI Development Innovations, LLC trials with current recruitment status updated daily.
Clinical Trials by SCRI Development Innovations, LLC
NCT07011576 Phase 2
Recruiting
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Colon Cancer
NCT06974786 Phase 2
Recruiting
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Multiple Myeloma, Newly Diagnosed
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology